NARLabs supplies high-quality specific pathogen free (SPF) laboratory animals and customized research one-stop service. The National Laboratory Animal Center (NLAC) of NARLabs establishes technological platforms to provide comprehensive tumor test-related resources and services including specialties of oncology, genetic modifications, animal-related experimentation, 3D medical imaging, and veterinary. NLAC also provides diversified tumor transplantation animal models, and anticancer drug efficacy assessments to facilitate drug development.
Establishment of laboratory animal care and surgery facility
Leading animal experiments to a new era for development of medical devices
NLAC established the "Laboratory Animal Care and Surgery Facility" to facilitate medical equipment innovation from prototype to marketing. The said facility features equipment and surgical space comparable to those used for human surgeries, fulf illing all related regulations, offering standardized services of animal surgery verif ication to domestic institutions. NLAC assists expediting the development process and success rate of medical device development while reducing costs expended for high-class medical devices in early trial periods. The goal is to foster the growth of Taiwan's advanced medical device industry.
Constituting a laboratory animal resource alliance
Connecting supply networks to provide a complete selection of laboratory animals
Following the rapid development of the global biomedical industry, laboratory animals have become important resources in preclinical animal studies. NLAC connects domestic and foreign lab animal supply units together to form an animal resource alliance that provides a complete selection of lab animals, including rabbits, dogs, pigs, and monkeys, to meet the demands of domestic users and elevate research standards.
Humanized mice made-in-Taiwan
Ideal model for drug tests that opens up li
NLAC is committed to developing prospective lab animals. After two years of enthusiastic efforts, NLAC has successfully established a useful mouse strain: advanced severe immunodeficiency (ASID). The said mice lack congenital and acquired immunity and generally do not reject heterologous cells and tissues. Therefore, human tissues or cells can be xenografted into ASID mice to accurately reflect the actual conditions in patients. Such model will be valuable for drug screening as well as for investigating the causes of diseases and ultimately for developing new therapies. These efforts will benefit significantly to the development and the quality of fundamental research and biomedical industries in Taiwan.
Customized research one-stop service (CROSS)
Integrating animal models with related technologies to provide customized animal experiment services as well as a tumor testing service
NLAC provides comprehensive tumor test-related resources and services including specialties of oncology, genetic modif ications, animal-related experimentation, 3D medical imaging, and veterinary. NLAC also provides diversified tumor transplantation animal models, and anticancer drug eff icacy assessments to facilitate drug development.